Overview
Compare with MEDICURE INC, PyroGenesis Canada Inc. or Adastra Holdings Ltd., or pick any stock.
- TickerHYFT on Nasdaq1
- Industrybiotechnology1
- HeadquartersAustin1
- Websitewww.mindwalkai.com
- Incorporated inBritish Columbia, Canada4
- Business address3204-4464 Markham Street, Victoria4
- Filer categoryNon-accelerated filer4
- Legal formCorporation
See how the biggest companies compare on our leaderboards

The Company was incorporated under the laws of Alberta on November 22, 1993 before continuing into British Columbia on September 2, 2016. On September 3, 2025, the Company changed its name to “MindWalk Holdings Corp. The address of the Company’s head office is Industrious 823 Congress Ave Suite 300 Austin, Texas 78701. The registered and record office of the Company is located at 1600 - 925, West Georgia Street, Vancouver, British Columbia V6C 3L2 , Canada. The Company’s agent in the U.S. in connection with this annual report, as well as its agent for service of process for its registration statements filed with the SEC, is ImmunoPrecise Antibodies (USA), Ltd., 3523 45th St S, Suite 100, PMB 5961, Fargo, North Dakota 58104, telephone number: (800) 620-4187.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Project Revenue brought in 99% of the revenue MindWalk broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Project Revenue | 10.0M CAD | 10.4M CAD | 15.4M CAD |
| Cryo Storage | 223.0K CAD | 222.0K CAD | 152.0K CAD |
| Product Sales | 21.0K CAD | 7.0K CAD | 1.0K CAD |
Regions
United States brought in 66% of the revenue MindWalk broke down this way in fiscal 2026.
Regions by year
| Regions | 2024 | 2025 | 2026 |
|---|---|---|---|
| United States | 8.4M CAD | 8.7M CAD | 10.3M CAD |
| Europe | 929.0K CAD | 393.0K CAD | 2.8M CAD |
| All Other Countries | 44.0K CAD | 440.0K CAD | 1.1M CAD |
| Australia | 482.0K CAD | 896.0K CAD | 1.1M CAD |
| Canada | 385.0K CAD | 234.0K CAD | 322.0K CAD |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue45¢11.0M CAD
- Research and development20¢4.9M CAD
- Other costs18¢4.4M CAD
- Interest1¢199.0K CAD
- Income tax16¢4.0M CAD
Out of 24.5M CAD in revenue.6 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.7
| Period ending | 2026-04-30 | 2025-04-30 | 2024-04-30 |
|---|---|---|---|
| REVENUE | 15.6M CAD | 10.6M CAD | 10.3M CAD |
| COST OF SALES | 6.4M CAD | 4.9M CAD | 6.2M CAD |
| GROSS PROFIT | 9.1M CAD | 5.7M CAD | 4.1M CAD |
| Research and development | 4.9M CAD | 4.2M CAD | 3.7M CAD |
| Sales and marketing | 5.9M CAD | 3.6M CAD | 2.9M CAD |
| General and administrative | 13.2M CAD | 12.1M CAD | 12.6M CAD |
| Impairment of Goodwill | 0 CAD | 0 CAD | 11.2M CAD |
| Impairment of Intangible assets | 0 CAD | 21.2M CAD | 3.9M CAD |
| Amortization of intangible assets | 0 CAD | 1.5M CAD | 2.4M CAD |
| Total expenses | 24.1M CAD | 42.6M CAD | 36.6M CAD |
| Loss before other income (expenses) and income taxes | -14.9M CAD | -36.9M CAD | -32.5M CAD |
| Accretion | 0 CAD | -10.0K CAD | -19.0K CAD |
| Grant and subsidy income | 33.0K CAD | 138.0K CAD | 299.0K CAD |
| Interest and other (expense) income | 87.0K CAD | -296.0K CAD | 22.0K CAD |
| Loss on disposal of discontinued operations | -511.0K CAD | 0 CAD | 0 CAD |
| Unrealized foreign exchange (loss) gain | -224.0K CAD | -555.0K CAD | 76.0K CAD |
| Other income (expenses) | -615.0K CAD | -723.0K CAD | 378.0K CAD |
| Loss before income taxes | -15.6M CAD | -37.6M CAD | -32.2M CAD |
| Income taxes | 450.0K CAD | 4.5M CAD | 2.9M CAD |
| NET LOSS FROM CONTINUING OPERATIONS | -15.1M CAD | -33.1M CAD | -29.3M CAD |
| NET INCOME FROM DISCONTINUED OPERATIONS | 1.2M CAD | 2.9M CAD | 3.2M CAD |
| NET LOSS FOR THE YEAR | -13.9M CAD | -30.2M CAD | -26.1M CAD |
| Exchange differences on foreign operations | 40.0K CAD | 1.1M CAD | -613.0K CAD |
| COMPREHENSIVE LOSS FOR THE YEAR | -13.9M CAD | -29.1M CAD | -26.7M CAD |
| LOSS PER SHARE FROM CONTINUING OPERATIONS - BASIC | -0.33 CAD | -0.99 CAD | -1.14 CAD |
| LOSS PER SHARE FROM CONTINUING OPERATIONS - DILUTED | -0.33 CAD | -0.99 CAD | -1.14 CAD |
| INCOME PER SHARE FROM DISCONTINUED OPERATIONS - BASIC | 0.02 CAD | 0.09 CAD | 0.12 CAD |
| INCOME PER SHARE FROM DISCONTINUED OPERATIONS - DILUTED | 0.02 CAD | 0.09 CAD | 0.12 CAD |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING | 46.4M shares | 33.4M shares | 25.6M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.7
| Period ending | 2026-04-30 | 2025-04-30 | 2024-04-30 |
|---|---|---|---|
| Cash | 11.3M CAD | 10.7M CAD | 3.5M CAD |
| Amounts receivable, net | 2.5M CAD | 4.1M CAD | |
| Tax receivable | 472.0K CAD | 143.0K CAD | |
| Inventory | 492.0K CAD | 2.1M CAD | |
| Unbilled revenue | 581.0K CAD | 548.0K CAD | |
| Prepaid expenses | 798.0K CAD | 1.2M CAD | |
| Total current assets | 16.2M CAD | 18.8M CAD | |
| Restricted cash | 126.0K CAD | 126.0K CAD | |
| Deposit on equipment | 25.0K CAD | 502.0K CAD | |
| Property and equipment | 4.0M CAD | 15.8M CAD | |
| Deferred tax asset | 958.0K CAD | 0 CAD | |
| Intangible assets | 0 CAD | 1.1M CAD | |
| Goodwill | 0 CAD | 8.2M CAD | |
| Total assets | 21.4M CAD | 44.4M CAD | |
| Accounts payable and accrued liabilities | 4.2M CAD | 5.3M CAD | |
| Deferred revenue | 1.1M CAD | 1.1M CAD | |
| Tax payable | 81.0K CAD | 475.0K CAD | |
| Leases | 457.0K CAD | 1.9M CAD | |
| Deferred acquisition payments | 0 CAD | 314.0K CAD | |
| Current liabilities | 5.8M CAD | 9.0M CAD | |
| Leases | 3.1M CAD | 11.6M CAD | |
| Deferred income tax liability | 769.0K CAD | 250.0K CAD | |
| Total liabilities | 9.6M CAD | 20.8M CAD | |
| Share capital | 137.3M CAD | 136.4M CAD | |
| Contributed surplus | 14.1M CAD | 12.8M CAD | |
| Accumulated other comprehensive income | 3.1M CAD | 3.2M CAD | |
| Accumulated deficit | -142.7M CAD | -128.8M CAD | |
| Equity | 11.7M CAD | 23.6M CAD | 35.7M CAD |
| Total liabilities and shareholders' equity | 21.4M CAD | 44.4M CAD |
| Period ending | 2026-04-30 | 2025-04-30 | 2024-04-30 |
|---|---|---|---|
| Cash | 11.3M CAD | 10.7M CAD | 3.5M CAD |
| Amounts receivable, net | 2.5M CAD | 4.1M CAD | |
| Tax receivable | 472.0K CAD | 143.0K CAD | |
| Inventory | 492.0K CAD | 2.1M CAD | |
| Unbilled revenue | 581.0K CAD | 548.0K CAD | |
| Prepaid expenses | 798.0K CAD | 1.2M CAD | |
| Total current assets | 16.2M CAD | 18.8M CAD | |
| Restricted cash | 126.0K CAD | 126.0K CAD | |
| Deposit on equipment | 25.0K CAD | 502.0K CAD | |
| Property and equipment | 4.0M CAD | 15.8M CAD | |
| Deferred tax asset | 958.0K CAD | 0 CAD | |
| Intangible assets | 0 CAD | 1.1M CAD | |
| Goodwill | 0 CAD | 8.2M CAD | |
| Total assets | 21.4M CAD | 44.4M CAD | |
| Accounts payable and accrued liabilities | 4.2M CAD | 5.3M CAD | |
| Deferred revenue | 1.1M CAD | 1.1M CAD | |
| Tax payable | 81.0K CAD | 475.0K CAD | |
| Leases | 457.0K CAD | 1.9M CAD | |
| Deferred acquisition payments | 0 CAD | 314.0K CAD | |
| Current liabilities | 5.8M CAD | 9.0M CAD | |
| Leases | 3.1M CAD | 11.6M CAD | |
| Deferred income tax liability | 769.0K CAD | 250.0K CAD | |
| Total liabilities | 9.6M CAD | 20.8M CAD | |
| Share capital | 137.3M CAD | 136.4M CAD | |
| Contributed surplus | 14.1M CAD | 12.8M CAD | |
| Accumulated other comprehensive income | 3.1M CAD | 3.2M CAD | |
| Accumulated deficit | -142.7M CAD | -128.8M CAD | |
| Equity | 11.7M CAD | 23.6M CAD | 35.7M CAD |
| Total liabilities and shareholders' equity | 21.4M CAD | 44.4M CAD |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.7
| Period ending | 2026-04-30 | 2025-04-30 | 2024-04-30 |
|---|---|---|---|
| Net loss for the year including discontinued operations | -13.9M CAD | -30.2M CAD | -26.1M CAD |
| Accretion | 0 CAD | 10.0K CAD | 19.0K CAD |
| Amortization and depreciation | 1.6M CAD | 5.1M CAD | 5.7M CAD |
| Asset impairment | 0 CAD | 21.2M CAD | 15.0M CAD |
| Deferred income taxes | -177.0K CAD | -3.9M CAD | -1.8M CAD |
| Foreign exchange | 331.0K CAD | 622.0K CAD | 15.0K CAD |
| Gain on investment | 0 CAD | -7.0K CAD | -2.0K CAD |
| Loss on disposal of subsidiary | 511.0K CAD | 0 CAD | 0 CAD |
| Share-based expense | 1.3M CAD | 445.0K CAD | 1.5M CAD |
| Items not affecting cash | -10.4M CAD | -6.8M CAD | -5.6M CAD |
| Amounts receivable | -1.6M CAD | -298.0K CAD | -601.0K CAD |
| Inventory | -53.0K CAD | 138.0K CAD | -102.0K CAD |
| Unbilled revenue | -690.0K CAD | -248.0K CAD | 360.0K CAD |
| Prepaid expenses | -397.0K CAD | 261.0K CAD | 624.0K CAD |
| Accounts payable and accrued liabilities | -216.0K CAD | 827.0K CAD | 983.0K CAD |
| Sales and income taxes payable and receivable | 236.0K CAD | 8.0K CAD | 733.0K CAD |
| Deferred revenue | 654.0K CAD | -302.0K CAD | 374.0K CAD |
| Net cash used in operating activities | -12.5M CAD | -6.4M CAD | -3.2M CAD |
| Purchase of equipment | -398.0K CAD | -799.0K CAD | -1.4M CAD |
| Security depost on leases | 0 CAD | 0 CAD | -141.0K CAD |
| Deferred acquisition payments | -312.0K CAD | 0 CAD | -146.0K CAD |
| Proceeds on disposal of subsidiary | 14.3M CAD | 121.0K CAD | |
| Net cash provided by (used in) investing activities | 13.5M CAD | -799.0K CAD | -1.6M CAD |
| Proceeds on share issuance, net of transaction costs | 897.0K CAD | 12.2M CAD | 2.4M CAD |
| Proceeds from debenture | 0 CAD | 4.2M CAD | 0 CAD |
| Repayment of principal on leases | -782.0K CAD | -1.6M CAD | -1.3M CAD |
| Net cash provided by financing activities | 115.0K CAD | 14.9M CAD | 1.0M CAD |
| Increase (decrease) in cash during the year | 1.2M CAD | 7.7M CAD | -3.7M CAD |
| Foreign exchange | -514.0K CAD | -438.0K CAD | -1.1M CAD |
| Cash paid for interest | 0 CAD | 0 CAD | 0 CAD |
| Cash paid for income tax | 0 CAD | 2.0K CAD | 0 CAD |
| Net cash used in operating activities | 777.0K CAD | 2.1M CAD | 2.9M CAD |
| Net cash used in investing activities | -100.0K CAD | -311.0K CAD | -1.2M CAD |
| Net cash used in financing activities | -359.0K CAD | -1.3M CAD | -1.1M CAD |
No quarter-by-quarter statement was filed.
Corporate structure
MindWalk sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of MindWalk
- INGALLS & SNYDER LLC Filed SCHEDULE 13G/A on MindWalk, latest Apr 23, 2026 (3 filings since Jul 7, 2023)
- Twee Charmquark Filed SCHEDULE 13G/A on MindWalk, latest Jan 24, 2025 (3 filings since Jan 10, 2024)
- MindWalk Austin
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What MindWalk reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | 15.8M CAD6 Apr 30, 2025 | 16.7M CAD6 Apr 30, 2024 | −5.6% |
| Operating-lease assets (leased space) | 13.4M CAD10 Apr 30, 2024 | 7.4M CAD11 Apr 30, 2023 | +79.6% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | 10.8M CAD6 Apr 30, 2025 | 3.5M CAD6 Apr 30, 2024 | +204.4% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | 8.2M CAD6 Apr 30, 2025 | 7.7M CAD6 Apr 30, 2024 | +7.1% |
| Intangible assets, net (excluding goodwill) | 1.1M CAD6 Apr 30, 2025 | 23.6M CAD6 Apr 30, 2024 | −95.5% |
Inventory
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive OfficerIlse Roodnik named Jul 30, 202412
- Director, Executive OfficerJennifer Bath named Jul 30, 202412
- Executive OfficerKristin Taylor named Jul 30, 202412
- DirectorBarry Springer named Jul 30, 202412
- DirectorChris Buyse named Jul 30, 202412
- DirectorDirk Witters named Jul 30, 202412
- DirectorMitch Levine named Jul 30, 202412
Former names
- ImmunoPrecise Antibodies Ltd.Aug 31, 2017 to Sep 3, 20254
Timeline
- 1983Founded Founded1
Filings
230 filings to the SEC since October 2021: 6 annual reports, 6 large holders, 1 private raises, 217 other. The latest 20:
- Oct 14, 20266-K EDGAR
- Oct 6, 20266-K EDGAR
- Oct 1, 20266-K EDGAR
- Sep 21, 20266-K EDGAR
- Sep 21, 20266-K EDGAR
- Sep 14, 20266-K EDGAR
- Sep 14, 20266-K EDGAR
- Sep 14, 20266-K EDGAR
- Sep 8, 20266-K EDGAR
- Jul 30, 2026EFFECT EDGAR
- Jul 28, 2026F-3/A EDGAR
- Jul 23, 20266-K EDGAR
- Jul 23, 202620-F EDGAR
- Jul 22, 20266-K EDGAR
- Jul 13, 2026F-3 EDGAR
- Jul 13, 20266-K EDGAR
- Jul 6, 20266-K EDGAR
- Jul 1, 20266-K EDGAR
- Jun 12, 20266-K EDGAR
- Jun 10, 20266-K EDGAR
The 230 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- INGALLS & SNYDER LLCSCHEDULE 13G/A, 3 filings Jul 7, 2023 to Apr 23, 202613
- Twee CharmquarkSCHEDULE 13G/A, 3 filings Jan 10, 2024 to Jan 24, 202514
Money raised
Private offerings the company reported to the SEC on Form D.
- Jul 16, 2024Raised $2 million in a private offering of debt Form D: $3 million offered in all Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 26. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How MindWalk is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARMindWalk Holdings Corp.2
- CIK0001715925
- Filer statusNon-accelerated filer not an emerging growth company; not a shell company5
- Incorporated inBritish Columbia5
- Fiscal year endsApril 302
- Industry code (SIC)2834 Pharmaceutical Preparations2
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance2
- Business address3204-4464 Markham Street, Victoria, British Columbia, British Columbia, Canada2
- Phone60480606262
- Shares outstanding46,711,866 shares as of Apr 30, 20265
- AuditorDavidson, Vancouver, Canada PCAOB ID 731; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceAug 31, 20172
- Filings282 in all: 6-K (226), 424B5 (6), 40FR12B/A (4), 6-K/A (4), D (4), EFFECT (4), 20-F (3), 40-F (3)2
All 27 form types
F-3 (3), SUPPL (3), F-X (2), FWP (2), S-8 (2), SC 13G (2), SCHEDULE 13G/A (2), 20-F/A (1), 40-F/A (1), 40FR12B (1), CERT (1), CORRESP (1), F-10 (1), F-10/A (1), F-3/A (1), SC 13D (1), SC 13G/A (1), SEC STAFF ACTION (1), UPLOAD (1)
- Latest filingsAnnual report (20-F) Jul 23, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Shares, no par value | HYFT | The Nasdaq Stock Market, LLC |
From the cover page of the 20-F filed Jul 23, 2026 (Section 12(b) of the Exchange Act).5
Links
- Websitewww.immunoprecise.com1
- Websitewww.mindwalkai.com1
- WikidataQ30282844
- SEC EDGARCIK 1715925
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMindWalk on Wikidata
- 2SEC EDGARMindWalk filings on SEC EDGAR
- 3Company websiteMindWalk logo
- 4SEC EDGARMindWalk filings on SEC EDGAR
- 5
- 6SEC EDGARMindWalk 10-K for fiscal 2025
- 7
- 8SEC EDGARMindWalk 10-K for fiscal 2020
- 9SEC EDGARMindWalk 10-K for fiscal 2021
- 10SEC EDGARMindWalk 10-K for fiscal 2022
- 11SEC EDGARMindWalk 10-K for fiscal 2022
- 12SEC EDGARMindWalk Form D naming Ilse Roodnik
- 13
- 14
